Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and tetraethylammonium

angiotensin ii, des-phe(8)- has been researched along with tetraethylammonium in 1 studies

Compound Research Comparison

Studies
(angiotensin ii, des-phe(8)-)
Trials
(angiotensin ii, des-phe(8)-)
Recent Studies (post-2010)
(angiotensin ii, des-phe(8)-)
Studies
(tetraethylammonium)
Trials
(tetraethylammonium)
Recent Studies (post-2010) (tetraethylammonium)
1,533219953,87710298

Protein Interaction Comparison

ProteinTaxonomyangiotensin ii, des-phe(8)- (IC50)tetraethylammonium (IC50)
Solute carrier family 22 member 1Mus musculus (house mouse)0.54
Solute carrier family 22 member 2Mus musculus (house mouse)3.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Carvalho, MH; de Cássia Tostes Passaglia, R; dos Santos, R; Fortes, ZB; Nigro, D; Oliveira, MA; Rastelli, VM1

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and tetraethylammonium

ArticleYear
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.
    Peptides, 2007, Volume: 28, Issue:5

    Topics: Angiotensin I; Animals; Animals, Newborn; Blood Glucose; Bradykinin; Diabetes Mellitus, Type 2; Drug Interactions; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Indomethacin; Insulin; Male; NG-Nitroarginine Methyl Ester; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Tetraethylammonium; Vasodilation

2007